Dyadic International, Inc. (DYAI) Q4 2025 Earnings Call Transcript

Operator

Good evening, and welcome to Dyadic International Full Year 2025 Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, March 25, 2026.

I would now like to turn the call over to Mrs. Ping Rawson, Dyadic’s Chief Financial Officer. Please go ahead.

Ping Rawson
Chief Financial Officer

Thank you, operator. Good evening, and welcome, everyone, to Dyadic’s Full Year 2025 Conference Call. I hope you have had the opportunity to review Dyadic’s press releases announcing financial results for the year ended December 31, 2025. You may access our release and Form 10-K under the Investors section of the company’s website at dyadic.com.

On today’s call, our President and Chief Operating Officer, Joe Hazelton, will review our full year 2025 business and corporate highlights and provide a commentary on the strategic direction of the business. Our CEO, Mark Emalfarb, will provide an update on our biopharmaceutical programs, and I will follow with a review of our financial results in more detail, after which we’ll hold a brief Q&A session.

At this time, I would like to inform you that certain commentary made in this conference call may be considered forward-looking statements, which involve risks and uncertainties and other factors that could cause Dyadic’s actual results, performance, scientific or otherwise or achievements to be materially different from those expressed or implied by these forward-looking statements. Dyadic expressly disclaims any duty to provide updates to its forward-looking statements, whether because of new information, future events or otherwise. Participants are directed to